Carvedilol has the capacity to block both the β-1 and β-2 adrenergic receptors, as well as the α-1 receptors. There is evidence to indicate that full adrenergic blockade by carvedilol improves ...

By contrast, a recent randomized, controlled trial shows less bleeding associated with the use of carvedilol compared with EBL. Portal hypertension is a life-threatening complication of cirrhosis ...